Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02528669 · ClinicalTrials.gov registry record · NA

Patient Ambulation in Post-Op Recovery

A NA study of Physical Activity, sponsored by Intermountain Health Care.

Completed
Registry status
NA
Development phase
52
Enrollment target
1
Study location

NCT02528669: Completed NA study of Physical Activity, sponsored by Intermountain Health Care.

NCT02528669 is a NA study of Physical Activity that has completed, run by Intermountain Health Care. The registered enrollment target is 52 participants, below the 358-participant average among 131 other Physical Activity trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02528669, a NA study of Physical Activity, has completed, sponsored by Intermountain Health Care.

COMPLETED
Registry status
NA
Development phase
52 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to create a platform that accurately measures and reports patient physical activity before a procedure, during the hospital stay, and after discharge from the hospital.

Conditions Studied

Interventions

  • DEVICE RX Navigait

Study Locations (1)

Utah

  • Intermountain Medical Center - Murray

Trial Details

FieldValue
Enrollment Target 52 participants
Start Date 2014-07-23
Est. Completion 2016-10-10
Phase NA
Intermountain Health Care

85 total trials

What the finished NCT02528669 record still lists

NCT02528669 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 52 participants, a relatively small participant target, below the 358-participant average among 131 other Physical Activity trials with a reported enrollment target (85% lower).

The record links to 1 condition, with Physical Activity appearing as the primary indexed condition, and to 1 intervention - of which RX Navigait is the first listed.

NCT02528669 reports a single indexed study location in Utah.

Frequently Asked Questions

What is clinical trial NCT02528669 about?

NCT02528669 is a clinical study titled "Patient Ambulation in Post-Op Recovery". The purpose of this study is to create a platform that accurately measures and reports patient physical activity before a procedure, during the hospital stay, and after discharge from the hospital.

What is the current status of trial NCT02528669?

This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2014-07-23. Estimated completion is 2016-10-10.

What conditions does trial NCT02528669 study?

This clinical trial studies the following conditions: Physical Activity.

What interventions are being tested in trial NCT02528669?

The interventions under investigation include: RX Navigait (DEVICE).

Who is sponsoring clinical trial NCT02528669?

This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02528669 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Physical Activity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02528669's enrollment target sits among peer trials

52 95th of 131 higher than 36 of 131 other Physical Activity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Physical Activity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02630121 · 52 participants · Phase 4

    Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea

  • NCT03629171 · 52 participants · Phase 2

    Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia

  • NCT04128748 · 52 participants · Phase 1

    Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome

  • NCT04150497 · 52 participants · Phase 1

    Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02528669, the US trial registry maintained by the National Library of Medicine. NCT02528669 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.